MAPK1 and cancer: This study highlights the potential of certain phytochemicals, such as luteolin (CID 5280445), hispidulin (CID 5281628), and isorhamnetin (CID 5281654), as potent inhibitors of the MAPK/ERK signaling pathway, which is crucial in RAS-driven cancers.